www.contemporarypediatrics.com Open in urlscan Pro
76.76.21.21  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 cursor-pointer bg-search-box-button-bg text-search-box-button-text hover:bg-search-box-button-hover-bg hover:text-search-box-button-hover-text ronded rounded-md p-1 font-bold w-[20%]"></form>

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 bg-search-box-button-bg text-search-box-button-text ronded rounded-md p-1 font-bold w-[20%]"></form>

Text Content

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

News
All News
PNP Corner
AAP News
Media
Around the Practice
Cure Connections
Expert Interviews
Insights
Medical World News
Peer Exchange
Peers & Perspectives
Podcasts
Webinars
Puzzler
Publications
Contemporary Pediatrics Journal
Supplements And Featured Publications
CME/CE
Resources
Handouts
Job Board
Sponsored
Conferences
Conference Coverage
Conference Listing
Partnerships
Subscribe
Print Subscription
eNewsletter
Editorial
Editorial Advisory Board
Writer’s Guidelines
Reference Guidelines
Meet the Editors



Spotlight
2022 Best TechCreating a Lasting Impact on the Future of SightFood Insecurity
and the Dangers of Infant Formula DilutionHelping to Advert Tragedy: Helping to
Protect Against Invasive Meningococcal DiseaseInfluenzaOpt-Out Chlamydia
Screening in Adolescent CarePediatric ADHD: Zeroing in on an Untenable BurdenRSV
RoundtableThe Role of the Healthcare Provider Community in Increasing Public
Awareness of RSV in All InfantsUpdate in Pediatric COVID-19 Vaccines
Clinical
Allergy, Immunology, and ENTCardiologyDermatologyDrug Pipeline NewsEmergency
MedicineEndocrinologyGastroenterologyGynecologyInfectious diseaseMental
HealthNeurologyNutritionOncologyPainPsychiatryRespiratoryRheumatoid
ArthritisSexual HealthView More
News
All News
PNP Corner
AAP News
Media
Around the Practice
Cure Connections
Expert Interviews
Insights
Medical World News
Peer Exchange
Peers & Perspectives
Podcasts
Webinars
Puzzler
Publications
Contemporary Pediatrics Journal
Supplements And Featured Publications
CME/CE
Resources
Handouts
Job Board
Sponsored
Conferences
Conference Coverage
Conference Listing
Partnerships
Subscribe
Print Subscription
eNewsletter
Editorial
Editorial Advisory Board
Writer’s Guidelines
Reference Guidelines
Meet the Editors

Choose a Specialty
 * Adolescent Medicine
 * Alcohol Abuse
 * Allergies and Infant Formula
 * Allergy, Immunology, and ENT
 * Animal Allergies
 * Autism
 * COVID-19
 * Cardiology
 * Dermatology
 * Developmental/Behavioral Disorders
 * Diabetes
 * Drug Pipeline News
 * Emergency Medicine
 * Endocrinology
 * Gastroenterology
 * Gynecology
 * Infectious disease
 * Influenza
 * Mental Health
 * Neurology
 * Nutrition
 * Obstetrics-Gynecology & Women's Health
 * Oncology
 * Pain
 * Pharmacology
 * Practice Improvement
 * Psychiatry
 * Respiratory
 * Rheumatoid Arthritis
 * Sexual Health
 * Telemedicine

Advertisement

Adolescent Medicine

| Alcohol Abuse

| Allergies and Infant Formula

| Allergy, Immunology, and ENT

| Animal Allergies

| Autism

| COVID-19

| Cardiology

| Dermatology

| Developmental/Behavioral Disorders

| Diabetes

| Drug Pipeline News

| Emergency Medicine

| Endocrinology

| Gastroenterology

| Gynecology

| Infectious disease

| Influenza

| Mental Health

| Neurology

| Nutrition

| Obstetrics-Gynecology & Women's Health

| Oncology

| Pain

| Pharmacology

| Practice Improvement

| Psychiatry

| Respiratory

| Rheumatoid Arthritis

| Sexual Health

| Telemedicine

View All >>
 * Adolescent Medicine
 * Alcohol Abuse
 * Allergies and Infant Formula
 * Allergy, Immunology, and ENT
 * Animal Allergies
 * Autism
 * COVID-19
 * Cardiology
 * Dermatology
 * Developmental/Behavioral Disorders
 * Diabetes
 * Drug Pipeline News
 * Emergency Medicine
 * Endocrinology
 * Gastroenterology
 * Gynecology
 * Infectious disease
 * Influenza
 * Mental Health
 * Neurology
 * Nutrition
 * Obstetrics-Gynecology & Women's Health
 * Oncology
 * Pain
 * Pharmacology
 * Practice Improvement
 * Psychiatry
 * Respiratory
 * Rheumatoid Arthritis
 * Sexual Health
 * Telemedicine

SPOTLIGHT -

Creating a Lasting Impact on the Future of Sight

| Helping to Advert Tragedy: Helping to Protect Against Invasive Meningococcal
Disease

| Influenza

| RSV Roundtable

| Food Insecurity and the Dangers of Infant Formula Dilution

| Opt-Out Chlamydia Screening in Adolescent Care

| Pediatric ADHD: Zeroing in on an Untenable Burden

| The Role of the Healthcare Provider Community in Increasing Public Awareness
of RSV in All Infants

| Update in Pediatric COVID-19 Vaccines

| 2022 Best Tech



LATEST NEWS

How to talk to your patients about weight issues
By Michelle Loy, MD, FAAP

March 11th 2024

What is the best way to bring up this often-sensitive topic so that children and
caregivers can work together for optimal health outcomes?

Addressing the mental health needs of sexual- and gender-diverse youth
By Ari S. Gzesh, MSW
Scott K. Jelinek, MD, MPH, MAEd
 * Renata Arrington Sanders, MD, MPH, SCM

March 11th 2024

Research has demonstrated that SGDY exhibit significantly elevated incidence of
mental health diagnoses and conditions compared with their counterparts,
including higher rates of suicidality, depressive and anxiety disorders, and
substance misuse.

Navigating the current shortages of pediatric ADHD medications
By Bailey Smith, PharmD
Luz Rosario, PharmD candidate
 * Janessa Maldonado, PharmD candidate
 * Tracy Nguyen, PharmD candidate
 * Kreena Patel, PharmD candidate
 * Caitlyn Bradford, PharmD, BCPPS

March 11th 2024

Understand how to naviate the current shortage of pediatric ADHD medications.

Outpatient visits for adolescent mental health nearly doubled from 2006-2019
By Joshua Fitch, Senior Editor

March 8th 2024

In the study period and among individuals aged 12 to 24 years, mental
health-associated visits increased nearly 2-fold from 2006 to 2019.

Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin
of color
By Joshua Fitch, Senior Editor

March 8th 2024

Data from a pair of identical, phase 3, double-blind, randomized, and
vehicle-controlled trials were presented at the 2024 American Academy of
Dermatology (AAD) Annual Meeting in San Diego, California.

Latest Videos
Identifying arrhythmias in children using smartwatch technology

Importance of maternal influenza vaccination recommendations

Reducing HIV reservoirs in neonates with very early antiretroviral therapy

Maternal influenza vaccination and associated infant hospitalizations

Providing background on very early neonatal antiretroviral therapy to restrict
HIV reservoirs

Remaining Knowledge Gaps in Influenza Vaccines

Addressing Guardian Concerns About Pediatric Influenza Vaccination

Goat milk-based infant formula: Benefits, data, and misconceptions

Discussing unintentional firearm injuries among children, and how preventable
they can be

Differences Between Egg-based and Cell-based Flu Vaccines

Pediatric Influenza Vaccination Recommendations

Complications of Pediatric Influenza

Pediatric Influenza Transmission

The clinical takeaways of the RSV immunizations

Reviewing the 2023 RSV season and an outlook on 2024

RSV Roundtable: Addressing the senior population

Podcasts
Demystifying Infant Formula

What's going on with polio, monkeypox, and COVID-19

Having "the talk" with teen patients

Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI

Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN

The Role of the Healthcare Provider Community in Increasing Public Awareness of
RSV in All Infants

Report Urges Increased Role of Health Community in Increasing Awareness of RSV
Disease

Addressing atypical anorexia: Part 3

Addressing atypical anorexia: Part 2

Meet the board: Michael S. Jellinek, MD

Continuing Medical Education

Archived WebcastCME

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current
Barriers and Opportunities for Improved Outcomes

View More




Patient, Provider, & Caregiver Connection™CME,CNE

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple
Sclerosis – Understanding Patient Challenges and the Role of Innovative
Treatment

View More




Archived WebcastCME,CNE

Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World
of Clinical Trials in Cholangiocarcinoma Treatment

View More




Archived WebcastCME

New Targets, New Treatments, and New Combinations for the Management of Advanced
Prostate Cancer

View More




Archived WebcastCME

From Trials to the Real World: Assessing the Role of Allogeneic Transplant and
JAK Inhibitors as Treatment Paradigms Evolve in Myelofibrosis

View More




In-Person + Virtual EventCME

Dialogues with the Surgeon on Integration of Systemic Therapies in Perioperative
Settings for NSCLC: What Do Current Data for IO- and ALK-Targeted Strategies
Tell Us?

March 19, 2024

Register Now!




Archived WebcastCME

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the
Opioid Epidemic

View More




Addressing Healthcare InequitiesCME

Addressing Healthcare Inequities: Tailoring Management Plans to Address
Healthcare Disparities in Cystic Fibrosis

View More






ALL NEWS



CDC estimates nirsevimab is 90% effective against RSV-associated
hospitalizations

By Joshua Fitch, Senior Editor
March 7th 2024


Though a small number of infants received nirsevimab in the analysis, results
support existing nirsevimab recommendations to prevent serious RSV disease in
infants.



Simple ways to focus on behavioral health in the primary setting

By Joshua Fitch, Senior Editor
March 7th 2024


Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, believes behavioral health
is currently at the forefront of pediatric health care and explains how simple
questions can lead to better care for a child.



Interim data: Seasonal influenza vaccine effective in reducing hospitalizations

By Joshua Fitch, Senior Editor
March 6th 2024


According to the data, vaccination coverage in the United States has been lower
in this influenza season compared to the previous season and to seasons before
the COVID-19 pandemic.



Benzene found in multiple acne treatment products

By Morgan Petronelli, Managing Editor
March 6th 2024


Results from a recent laboratory test revealed benzene was found in multiple
benzoyl peroxide acne products.



First over-the-counter continuous glucose monitor FDA-cleared

By Joshua Fitch, Senior Editor
March 6th 2024


The device is intended for anyone aged 18 years and up who do not use insulin or
those without diabetes who want to learn how diet can impact blood sugar levels.



What is the psychosocial impact of cutaneous diseases on children?

By Ilya Petrou, MD
March 5th 2024


Health care providers must not only address the physical symptoms of patients
with skin disorders but also the psychological fallout frequently associated
with these diseases.



With the correct research, AI in pediatric cardiology has great potential

By Joshua Fitch, Senior Editor
March 5th 2024


Scott Ceresnak, MD, explains ways AI technology could be useful when it comes to
pediatric cardiology, though he states "big" research data is needed to generate
pediatric specific algorithms.



Goat milk-based infant formula: What pediatricians need to know

By Ari Brown, MD, FAAP
March 5th 2024


Historically, the AAP-approved options for infant formula sold in the United
States were cow-milk-based, soy milk-based, or specialty infant formulas. Goat
milk-based infant formulas have been used for decades worldwide, but only
recently entered the US formula market.



FDA approves Perflutren Lipid Microsphere for pediatric patients with suboptimal
echocardiograms

By Joshua Fitch, Senior Editor
March 4th 2024


The federal agency approved Perflutren Lipid Microsphere following positive data
from 3 pediatric clinical trials.



FDA approval sought for mirdametinib in NF1-PN

By Courtney Flaherty
March 4th 2024


SpringWorks Therapeutics has initiated a new drug application for mirdametinib
in neurofibromatosis type 1-associated plexiform neurofibromas.



Week in review: Teen antidepressant use during COVID, expert reaction to
omalizumab data

By Joshua Fitch, Senior Editor
March 4th 2024


Review some of the top stories from the Contemporary Pediatrics website over the
last week, and catch up on anything you may have missed.



Contemporary Pediatrics' March mental health issue

By Tina Q Tan, MD, FAAP, FIDSA, FPIDS
March 2nd 2024


Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights our March Mental
Health issue of Contemporary Pediatrics.



CDC removes 5-day COVID-19 isolation guidelines

By Joshua Fitch, Senior Editor
March 1st 2024


Guidance now aligns with isolation recommendations for influenza and other
respiratory illnesses.



Walgreens and CVS to distribute mifepristone

By Celeste Krewson, Assistant Editor
March 1st 2024


Walgreens and CVS pharmacies are set to dispense mifepristone in select states,
aiming to address legal complexities and enhance accessibility amidst ongoing
regulatory and legal battles.



Viaskin milk patch demonstrates mixed results, phase 1/2 data shows

By Patrick Campbell
March 1st 2024


Viaskin milk patch shows promise in cow’s milk allergy, particularly in children
aged 2-11 with 300 μg dose, though the other doses examined failed to prove
significant benefit.



Poll: How parents feel about noise exposure from their child's headphones

By Joshua Fitch, Senior Editor
February 29th 2024


Across all age groups polled, 49% of parents agreed that using headphones helped
keep their child entertained.



Experts share their thoughts on the omalizumab OUtMATCH phase 3 data

By Joshua Fitch, Senior Editor
February 29th 2024


Study authors of a paper published in The New England Journal of Medicine
highlighting omalizumab for multiple common food allergies provided their
comments regarding positive phase 3 data.



Can smartwatch technology identify arrhythmias in children with adult
algorithms?

By Joshua Fitch, Senior Editor
February 28th 2024


Scott Ceresnak, MD, explains smartwatch technology could be a great tool in
detecting arrhythmias in children, however, given that algorithms in the
technology were designed for adults, caution must be used as well.



The role of the pediatrician in school-based mental health services

By Joshua Fitch, Senior Editor
February 28th 2024


"Collaboration can help us make more accurate diagnoses, develop more effective
multimodal treatment plans, and monitor progress in many areas," said James
Wallace, MD.



Long-term safety of epicutaneous immunotherapy with DBV712 for peanut allergy

By Joshua Fitch, Senior Editor
February 27th 2024


A poster presentation at AAAAI from the phase 3 PEOPLE Study revealed DBV712
treatment in children with peanut allergy has a favorable safety and
tolerability profile.



Female teen antidepressant use rose, male teens saw a decline amid COVID-19

By Chelsie Derman
February 27th 2024


A new study found female teens and young adults were more likely to have an
increased antidepressant dispensing rate during the pandemic than male peers.



Omalizumab increases reaction threshold for multiple common food allergies

By Joshua Fitch, Senior Editor
February 26th 2024


Omalizumab was approved by the FDA on February 16, 2024 as the first and only
FDA-approved medicine to reduce allergic reactions in patients with 1 or more
food allergies.



Week in review: Neffy repeat dose study data, fostering healthy eating habits

By Joshua Fitch, Senior Editor
February 26th 2024


Review some of the top stories from the Contemporary Pediatrics website over the
last week, and catch up on anything you may have missed.



Neffy for patients with anaphylactic symptoms after oral food challenge

By Joshua Fitch, Senior Editor
February 23rd 2024


Thomas Casale, MD, discusses phase 3 data presented at the 2024 AAAAI Meeting in
Washington DC, highlighting neffy's efficacy in pediatric patients at risk for
anaphylaxis.



Clinician quiz: AAP clinical practice guideline for treatment of children with
obesity

By Joshua Fitch, Senior Editor
February 23rd 2024


Take this short quiz and test your knowledge of the American Academy of
Pediatrics' clinical practice guideline to evaluate and treat children and
adolescents with obesity.


See All News >
Advertisement

Recent Content

How to talk to your patients about weight issues



Addressing the mental health needs of sexual- and gender-diverse youth



Navigating the current shortages of pediatric ADHD medications



Outpatient visits for adolescent mental health nearly doubled from 2006-2019

View More Recent Content
Advertisement

Advertisement

x

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777



© 2024 MJH Life Sciences

All rights reserved.